| Literature DB >> 30970753 |
Roberto Scaffaro1, Andrea Maio2, Francesco Lopresti3, Luigi Botta4.
Abstract
Electrospinning is a versatile process technology, exploited for the production of fibers with varying diameters, ranging from nano- to micro-scale, particularly useful for a wide range of applications. Among these, tissue engineering is particularly relevant to this technology since electrospun fiEntities:
Keywords: CNTs; antimicrobial properties; biopolymer; electrical properties; electrospinning; fullerene; graphene; mechanical properties; nanodiamonds; tissue engineering
Year: 2017 PMID: 30970753 PMCID: PMC6432463 DOI: 10.3390/polym9020076
Source DB: PubMed Journal: Polymers (Basel) ISSN: 2073-4360 Impact factor: 4.329
Figure 1Schematic representations of (A) Conventional electrospinning setup; (B) parallel electrodes setup for aligned fibers; (C) coaxial electrospinning setup for core shell fibers.
Figure 2Laser scanning confocal microscopy micrographs of immunostained neurofilament 200 kD in neuronal stem cells after 2 days of culture; (a) on aligned nanofibers, low magnification (×200); (b) on aligned nanofibers, high magnification (×400); (c) on aligned microfibers; low magnification (×200) and (d) on aligned microfibers, high magnification (×400) Reprinted from [62] with permission from Elsevier.
Figure 3Schematic illustration of some nanocarbon. Reprinted with permission from [79]. Copyright (2013) American Chemical Society.
Nanocarbons examined in this review: some properties of interest.
| Nanocarbons for TE | Mechanical properties | Electrical properties | Biological properties | |||||
|---|---|---|---|---|---|---|---|---|
| Class and Geometry | Type | TS (GPa) | CCM (cm2/V·s) | Band gap (eV) | Conductivity (S/cm) | Cytotoxicity | Antibacterial activity | |
| CNT-family (1D) | SWCNTs | 1–1.3 [ | 13–52 [ | 1 × 105 [ | 0.01–0.5 [ | 102–103 [ | Strong [ | Strong [ |
| DWCNTs | 1.25 [ | 45 [ | 1 × 105 [ | 0.01–0.5 [ | 102–103 [ | Strong [ | Strong [ | |
| MWCNTs | 0.2–0.9 [ | 1.7 [ | 1 × 105 [ | 0.01–0.5 [ | 102–103 [ | Moderate [ | Moderate [ | |
| Graphene family (2D) | Graphene | ~1 [ | 130 [ | 2 × 105 [ | 0 [ | 104 [ | High [ | Moderate [ |
| GO | 0.25–0.4 [ | 30–60 [ | Var [ | Var [ | 10−1 [ | Low [ | Strong [ | |
| RGO | 0.1–0.4 [ | 30–99 [ | 1 × 105 [ | 0.01–0.05 [ | 102–104 [ | Moderate [ | Moderate [ | |
| Other nanocarbons (0D) | Fullerenes | N/A | N/A | 6 [ | 1.5–2.3 [ | 102–104 [ | Moderate [ | N/A |
| NDs | 1–1.3 | N/A | 103–104 [ | 5.5 [ | 10−2 [ | Low [ | N/A | |
N/A: Not available; Var: Variable; CCM: Charge carrier mobility.
Figure 4AFM images of the as prepared graphene oxide (GO) sample. (a) top view; (b) height profile of the region marked by the white line through the crosses in panel (a); (c) 3D view evidencing the wrinkling size. Reprinted from [118] with permission from Elsevier.
Examples of polymer-CNTs electrospun scaffolds for tissue engineering.
| Polymers (and additives) | Solvents | Nanocarbons | Nanocarbons loading (wt %) | Experimental setup | Structure | Main improvements | Target tissue | Refs. |
|---|---|---|---|---|---|---|---|---|
| CA/CS | Acetone/DMF (2:1) | MWCNT | N/A | electrospinning plus layer-by-layer self-assembly | Random, | Mechanical properties; cell attachment, spreading and proliferation | Not specified | [ |
| Gelatin | Water | MWCNT | N/A | Electrospinning followed by crosslinking with GA vapor | Aligned, | Mechanical properties; cell alignment and differentiation | Muscle | [ |
| PANI/PNIPAm- | HFIP/DMF (8:2) | PANI-MWCNT | N/A | Conventional electrospinning | Random , | Cell growth and viability | Not specified | [ |
| PANI/PNIPAm | HFIP/DMF (8:2) | HOOC-MWCNT | N/A | Conventional electrospinning | Random , | Cell proliferation and viability | Not specified | [ |
| PBAT | Chloroform/DMF (3:2) | MWCNT (plasma treated with O2) | 0.1%–0.5% | Conventional electrospinning | Random, | Mechanical properties | Bone | [ |
| PCL | DCM/methanol (3:1) | MWCNT (acid-treated) | 0.1%–5% | Conventional electrospinning | Random, D = 117±45–252 ± 146 nm | Accelerating degradation behavior; biocompatibility | Not specified | [ |
| PCL–PAA/PVA | DMF/DCM (1:1)–EtOH/H2O | MWCNT (acid-treated) | 0.05% | Coaxial electrospinning | Random, | Mechanical and electrical properties; biocompatibility | Skeletal muscle | [ |
| PELA | DMF/DCM | MWCNT | 0%–6% | Coaxial electrospinning | Aligned, | Mechanical and electrical properties; cell morphology | Myocardial | [ |
| PLA | Chloroform/DMF | MWCNT | 0%–1% | Conventional electrospinning | Random, | Mechanical and electrical properties | Not specified | [ |
| PLA | DCM/DMF (3:1) | MWCNT | 1% | Conventional electrospinning | Random, | Mechanical and electrical properties | Cartilage | [ |
| PLA | DMF/DCM | MWCNT (acid-treated) | 0%–5% | Conventional electrospinning | Random, | Mechanical and electrical properties; cell morphology | Bone | [ |
| PLCL | DCM/EtOH (4:1) | MWCNT-tartrate | N/A | MWCNT coating on electrospun PLCL | Aligned, | Cell adhesion, proliferation and neurite outgrowth | Nerve | [ |
| PLGA | DMF/THF (3:1) | MWCNT | 0.1%–1% | Conventional electrospinning | Random, | Electrical properties; myotube formation | Skeletal muscle | [ |
| PLGA | DMFA | MWCNT | N/A | electrospinning onto MWCNT knitted scaffold | Random | Cell spanning | Nerve | [ |
| PLGA/SF/catalpol | HFIP | MWCNT | N/A | Conventional electrospinning | Random, | N/A | Nerve | [ |
| PLLA | Chloroform/DMF (9:1) | MWCNT-PhOMe | 0.25% | Conventional electrospinning | Random, | Neurite outgrowth and neuronal cell differentiation | Nerve | [ |
| PLLA | Chloroform/DMF (8.5:1.5) | SWCNT | 3% | Conventional electrospinning | Aligned, | Cell adhesion, growth, survival and proliferation | Nerve | [ |
| PLLA/HA | DCM/1,4-dioxane | MWCNT (anodic oxidated) | 0.3% | Conventional electrospinning | Random, | Cell adhesion and proliferation. | Periodontal ligament | [ |
| PU | THF/DMF (1:1) | MWCNT | 0.1%–1% | Conventional electrospinning | Random, | Mechanical properties | Not specified | [ |
| PU | DMAc | MWCNT (acid-treated) | 3% | Conventional electrospinning | Random, | Cell adhesion, proliferation, migration and aggregation | Not specified | [ |
| PU | DMAc | MWCNT (acid-treated) | 3% | Conventional electrospinning | Aligned, | Cell proliferation, extracellular collagen secretion | Vascular | [ |
| PVA/CS | AA/water (70 wt %) | MWCNT | 0.99% | Electrospinning followed by crosslinking with GA vapor | Random , | Cell proliferation; protein adsorption capability | Not specified | [ |
| SF | Water | MWCNT (functionalized with SDBS) | 0.25%–1.5% | Conventional electrospinning | Random, | Mechanical properties | Not specified | [ |
| SF | Formic acid | SWCNT | 1% | Co-electrospinning plus treatment with methanol and/or stretching | Random , | Mechanical and electrical properties | Bone | [ |
| SEBS | Toluene/THF (1:1) | MWCNT | 1.5% | Conventional electrospinning | Random, | Mechanical hysteresis and electrical conductivity | Not specified | [ |
N/A: Data not available; D: Diamater; The other acronyms are available in the acronym list.
Figure 5(a) Typical stress–strain curves of blend and coaxially electrospun fibrous mats containing 5% of carbon nanotubes (CNTs). (b) Young’s modulus, (c) elongation at break and (d) conductivity of blend and coaxially electrospun fibrous mats containing different amounts of CNTs. Reprinted from [130] with permission from Elsevier.
Figure 6Histologic examination of cell/membrane composites implanted into immunodeficient mice: (a–c) show new-formed bonelike tissues in round or irregular shape (white arrow), and osteoblast-like cells were well arranged around bonelike tissues. Abundant blood vessels were found in the implanted area. In (c), alizarin red staining confirmed calcium deposits in new-formed bonelike tissues. In (d), osteocalcin, which was stained in brown, was detected in the cytoplasms and outside the cells. Reprinted with permission from [143]. Copyright (2007) American Chemical Society.
Figure 7(a,b) Typical SEM and (c,d) TEM images of blend (a,c) and coaxially electrospun fibers (b,d) containing 5% CNTs. Insets in c and d show the physical appearance of fibrous mats obtained. Reprinted from [130] with permission from Elsevier.
Examples of polymer-graphene electrospun scaffolds for tissue engineering.
| Polymers (and additives) | Solvents | Nanocarbons | Filler loading (wt %) | Structure | Main improvements | Target tissue | Refs |
|---|---|---|---|---|---|---|---|
| CS/GEL/HA | AA/H2O | GO; RGO | 2% | Random | Bioactivity, antibacterial and mechanical properties | Bone | [ |
| CS/PEO/BC | AA/H2O | GO | 0–2 | Random | Mechanical properties | Skin | [ |
| CS/PVP/PEO | AA/H2O | GO | 0–2 | Random, | Mechanical properties, bioactivity | Skin/bone | [ |
| GEL | DMSO | GO- | 2–3 | Random, | Mechanical and electrical properties, wettability | Not specified | [ |
| PAN | DMF | GO; RGO | N/A | Random | Mechanical, electrical properties | Not specified | [ |
| PCL | CHCl3 | GO | N/A | Random, | Mechanical, electrical, cell signaling | Skeletal muscle | [ |
| PCL | CHCl3 | GO | 0.3–2 | Random, | Mechanical, electrical properties, bioactivity | Muscle | [ |
| PCL | DMF | GO | 0.3–0.5 | Random; | Cell differentiation | Nerve/cartilage | [ |
| PCL | DMF | GO | 0.5–2 | Random, | Mechanical properties, bioactivity, biodegradability | Bone | [ |
| PCL | DCM/EtOH 4:1 | GO; GO- | 0.25–2 | Random, | Mechanical, wettability, cell adhesion | Osteochondral | [ |
| PCL | AA | GO; RGO | 0–1 | Aligned, | Mechanical properties | Not specified | [ |
| PLA | CHCl3/DMF | GO; GO- | 2 | Random, | Mechanical properties | Osteochondral | [ |
| PLA/HA | DCM/DMF | GO | 1–3 | Mechanical, bioactivity | Bone | [ | |
| PLA/PU 4:1 | DMF/DCM 2:3 | GO | 5 | Random, | Biocompatibility, antimicrobial properties | Cartilage | [ |
| PLGA | THF/DMF | GO | 1 | Wettability, bioactivity | Bone | [ | |
| PLGA/Col | HFIP | GO | 4 | Random, | Cell proliferation, mechanical properties | Bone/muscle | [ |
| PLGA/RGD | HFIP | GO | N/A | Random, | myogenic differentiation | Bone/muscle | [ |
| PLGA/SF | HFIP | GO | 1 | Random, | Mechanical, wettability, cell differentiation | Bone | [ |
| PLLA | HFIP | GO | N/A | Aligned; | Cell differentiation and growth | Nerve | [ |
| PU | DMF | GO | 0.5-2 | Mechanical properties, bioactivity | Osteochondral | [ | |
| PVA | H2O | GNS | 1%–7% | Random, | Electrical properties | Cartilage | [ |
| PVA | H2O | GO | 0-5 | Random, | Mechanical properties, bioactivity | Bone | [ |
| PVA/CS | AA/H2O | GO | 0.05–0.6 | Mechanical properties | Skin | [ | |
| PVC; FN | THF/DMF (4:1) | GO; RGO | N/A | N/A | Mechanical, electrical properties, bioactivity | Nerve | [ |
| SF | H2O | GO; RGO | N/A | Electrical properties | Nerve | [ |
N/A: Data not available; D: Diamater; The other acronyms are available in the acronym list.
Figure 8Electronic images show (a) surgery process of implantation of nanofibrous membranes on the open wound of a rat, and wound healing 14 days post-surgery for (b) pristine chitosan (CS)-based mat and (c) 1.5% GO-containing membrane. (d) Wound closure rate for the examined materials compared with the control (sterile gauze sponge). Reprinted from [152] with permission of Elsevier.
Figure 9Mechanical properties of the electrospun fibrous pure poly(lactic-co-glycolic acid) (PLGA), PLGA–tussah, and GO-doped PLGA–tussah mats (n = 10 for each type of nanofibers) tested at room temperature. (A) Typical stress–strain curves; (B) tensile strength; (C) Young’s modulus; and (D) strain at break (* p < 0.05, ** p < 0.01). Reprinted from [165] with permission from Elsevier.
Figure 10(A) SEM image of electrospun: (a) polycaprolactone (PCL); (b) PCL/GO 0.25 wt %; (c) PCL/GO 0.5 wt %; (d) PCL/GO 1.0 wt %; (e) PCL/GO-g-PEG 0.25 wt %; (f) PCL/GO-g-PEG 0.5 wt %; (g) PCL/GO-g-PEG 1.0 wt %. Scale bars are 20 μm. (B) Diameter distribution for electrospun PCL, PCL/GO and PCL/GO-g-PEG nanocomposites obtained with ImageJ. Reprinted from [7] with permission from Elsevier.